Sexual Health in Armenia Looking:” Life with Hiv Page 3

Total Page:16

File Type:pdf, Size:1020Kb

Sexual Health in Armenia Looking:” Life with Hiv Page 3 “YOU CAN’T TELL BY SEXUAL HEALTH IN ARMENIA LOOKING:” LIFE WITH HIV PAGE 3 WHY NOT TALKING ABOUT SEX IS BAD FOR YOUR HEALTH PAGE 4 DECEMBER 2008 WHY YOU SHOULD GET STI TESTED BEFORE D i s t r i b u t e d i n c o o p e r a t i o n w i t h A r m e n i a n n e w s p a p e r s GETTING PREGNANT Aravot, Novoye Vremya, Noyan Tapan, Ban u gorts, Kamq+. Talin Askhkarh, Lusardzak, Vorotan, Syunyats Yerkir, PAGE 5 Vanadzoryan Khchankar, Sevan, Hingshabti, Shrjadardz, Tufashkharhi Arorya Cover Art by “This Month” Design Team “IE A RED On December 1, people wear red ribbons to show they have joined the fight against HIV and AIDS. RIBBON Go to www.worldaidsday.org to order free ribbons and find out more about the deadly virus. NEXT MONTH: The Armenian government is dramatically overhauling pensions, affecting not only the elderly, but anyone who is old enough to work. Find out how the changes affect you in our next issue, Pensions and You, out Feb. 1 2 SEXUAL HEALTH IN ARMENIA DECEMBER This publication is made possible through the generous support of the American people through the United States Agency for International Development (USAID). The content does not necessarily reflect the views of IREX, the Primary Health Care Reform Project, USAID, or the US government. he most shocking affect the health of you, your partner, and even your unborn thing about HIV is children (pages 4-5). It’s true that Armenians traditionally don’t ²Ûë ÃáÕ³ñÏáõÙÁ Ñݳñ³íáñ ¿ ¹³ñÓ»É ²ØÜ T ÅáÕáíñ¹Ç` ²ØÜ ÙÇç³½·³ÛÇÝ ½³ñ·³óÙ³Ý not the stealth with talk about sex, but how much does the silence harm us and ·áñͳϳÉáõÃÛ³Ý ÙÇçÝáñ¹áõÃÛ³Ý ßÝáñÑÇí: which it slips into a those we love? ä³ñï³¹Çñ ã¿, áñ ÃáÕ³ñÏÙ³Ý μáí³Ý¹³ÏáõÃÛáõÝÝ ³ñï³óáÉÇ population or the horrif- Even if we want to talk about sex, it’s still an uncomfortable §²Úèºøê¦-Ç, ²éáÕçáõÃÛ³Ý ³é³çݳÛÇÝ ic way it kills. subject, and the question becomes how to broach it. Find out å³Ñå³ÝÙ³Ý μ³ñ»÷áËáõÙÝ»ñÇ Íñ³·ñÇ, ²ØÜ Ø¼¶ It’s the physical what some vocal Shirak women did to protect their sexual ϳ٠²ØÜ Ï³é³í³ñáõÃÛ³Ý ï»ë³Ï»ïÝ»ñÁ: beauty of the virus health (Page 4). It raises more questions: what should we be itself. teaching our children in school (Page 7)? In particular, what Managing Editor, Content: Leah Kohlenberg The latest micro- harm are we doing to our daughters by forcing them to be Armenian Editor: Gayane Abrahamyan scopic images made silent and ashamed of their sexual life, rather than teaching available to us by the them to take responsibility for their sexual health? (Page 6) Supplement Coordinator: Hermine Andreasyan world’s HIV scientists It is also important how we treat those people living with Medical Consultant: Dr. Karine Abelyan, NOVA show how the night- the disease. HIV is not an infection that stalks the “guilty.” mare for nearly 40 million people around the globe living with Read about how a traditional Armenian woman contracted Contributing Reporters Gayane Abrahamyan, Lena Nazaryan, Alla Ayvazyan, Gayane Sargsyan, HIV unfolds inside the body like an intricately woven lace pat- HIV, which took her child and changed her life forever Sara Khojoyan, Naira Bulghadaryan, tern. It also spreads through sex, something that should be (page 3). Ani Stepanyan, Christine Vardanyan, Karine beautiful, which is why we chose to show on our cover (see Lastly, we must examine the politics of HIV and sexual Hunanyan, Mane Grigoryan, Tatevik Sargsyan above phote) images of the virus imposed upon the profile of health. How is the Armenian government’s promotion of an Design Consultant: Ed Henninger a loving couple. Love is beautiful, and so, unfortunately is HIV. experimental, locally produced HIV treatment helping or hurt- Layout Design: Vahe Dionesyan This issue has been timed to be published on Dec. 1, in ing Armenians living with HIV? (See story below) Graphics: Levon Nikolyan, conjunction with World AIDS Day. Think that doesn’t have any- Liana Karakhanyan, Anna Satyan thing to do with you? There are an estimated 36,000 sexually HIV has changed the world, and it is changing Armenia, transmitted infections (STIs) amidst the population. Most of too. Let’s start an “information revolution” that spreads as Photography: Anahit Hayrapetyan the time, these infections are symptom-less and curable, but quickly as the HIV virus: by overcoming taboos, and talking Proofreader: Taguhi Susliyan that doesn’t mean they aren’t dangerous: read how STIs can about our sexual lives in a responsible way. îå³·ñí³Í ¿ §îÇ·ñ³Ý ػͦ Ññ³ï³ñ³ÏãáõÃÛ³Ý ïå³ñ³ÝáõÙ: îå³ù³Ý³ÏÁ` 31000 Armenicum or nothing? Ten Years On, the So-Called “Miracle Cure” Still Unproven By Sara Khojoyan be treated with Armenicum, while the stan- Barseghyan said. “But as the HIV problem monitoring the 250 patients who have been and Leah Kohlenberg dard ARV regimen costs $1,700 per patient gets worse, it will be more difficult to bring treated with the drug in the past four years, Amnewsservice.org per year. The Armenian taxpayer paid enough drugs into the country.” though they contend “many” have lived for $300,000 to treat 50 Armenicum patients When Armenicum was first introduced ten years using the drug. For ten years, Armenians have been this year, while the Global Fund paid in Armenia ten years ago, founders called it “Armenicum is still experimental and we told about the wonders of Armenicum, the $160,000 to treat 93 patients with ARV a “revolutionary cure for AIDS,” and it are in the middle of the testing phase,” said locally produced formula whose makers drugs. In other words, it costs twice as immediately captured high-ranking govern- Ashot Melkonyan, head of the Armenicum claim it has curative powers over the dead- much to treat half as many Armenicum ment officials’ interest. Early on, initial pay- Clinical Center in Yerevan. “But when we ly HIV virus. patients. ments for Armenicum treatments came are ready, we will show the world what we And while doctors who use the drug say So far, the U.S.-funded Global Fund, from the Defense Ministry in an effort to have.” it does seem to relieve some of the symp- through the local World Vision Armenia promote the drug’s research and develop- Despite the lack of evidence supporting toms of HIV, after a decade the company office, has been paying for and procuring ment. Armenicum’s possibilities caused a Armenicum’s claims, the National Center has yet to produce any viable clinical trials ARV treatments. But technically, that buzz of excitement in the tiny country. for AIDS Prevention clinicians say they proving more substantive treatment claims. money ran out in June, and though the Businessmen, it was reported in some consider Melkonyan and the Armenicum What most Armenians probably don’t grant has been extended until February newspapers in 1999, were buying property doctors colleagues in the fight against HIV, know is that their tax dollars are paying for and the National Center for AIDS so that they could rent it to all the people and have supported anecdotal claims that Armenicum, which is more than triple the Prevention is currently applying for another who would fly to Armenia to take the cure. some of their patients have responded well cost of the world’s only proven treatment grant, this one for six years, there is no Yet a decade on, only about 800 people to the treatment. for HIV, Anti Retroviral (ARV) drugs. They guarantee that the Global Fund will contin- have actually taken Armenicum. “We are cooperating all the time, and probably also aren’t aware that in a few ue to fund future ARV treatments for newly Worldwide, the most effective treatment we always discuss every case to find a bet- months Armenicum may be the only choice revealed cases. for HIV are Anti Retroviral drugs, which in ter solution,” said Dr. Arshak Papoyan, available in Armenia for future HIV-infected “If the Global Fund does not finance internationally accepted clinical trials have head of the National Centre for AIDS people. Armenia again, the national HIV program been the only proven way to keep patients Prevention Epidemiology Unit. In Armenia, treating HIV positive will be in great jeopardy,” said Mark Kelly, alive, often for years. The drugs work by But it’s hard to find a doctor treating HIV patients shouldn’t be a major problem – World Vision Armenia’s National Director. directly attacking and reducing the amount patients who will be quoted publicly saying and on the surface, the system seems to be “Currently the Global Fund pays for the of HIV virus in the body, keeping the patient the drug doesn’t work, some say, because working. The HIV positive population is majority of testing and prevention pro- from developing Acquired Immunodeficiency the pressure for the Armenian-made drug small, with only 649 reported cases. Even grams, and all ARV treatments.” Syndrome (AIDS), a complete immune sys- to succeed is so high that criticism is con- including the estimated 3,000 unreported Compounding the problem, according tem failure which leads to death. The drugs, sidered unpatriotic. cases out there, they still make up a mere to World Vision Procurement Officer Mher offered in cocktails of three or four at a time, “I know many clinicians who don’t .01 percent of the total population.
Recommended publications
  • Hiv/Aids and Its Impact Hiv/Aids
    Section 1 HIV/AIDS and its impact Section 2 Legal and policy HIV/AIDS AND ITS IMPACT framework Section 3 Employers need a clear understanding of HIV/AIDS and the impact of the epidemic in order to plan a workplace programme. Developing workplace policies This Section helps you fi nd basic information about inf HIV and inf AIDS, and their implications for society as a whole as well as for Section 4 the world of work. Implementing workplace programmes To view the contents, click on the headings on the left or scroll through the pages. Section 5 Good practice and lessons learnt HIV/AIDS - the facts The Human Immunodefi ciency Virus (HIV) is a virus that weakens the body’s immune system, ultimately causing AIDS. The Acquired Immune Defi ciency Syndrome (AIDS) is a cluster of medical conditions linke to HIV infection. These conditions include diseases known as inf 2 opportunistic infections, as well as certain cancers. To date there is no cure, but the onset of AIDS can be slowed and symptoms relieved with the appropriate use of antiretroviral drugs (ARVs). A person with HIV is not necessarily sick, and can go on working for a number of years after infection. ARVs make it possible for people to continue living full and productive lives. You are in Section 1 The ILO Code of Practice on HIV/AIDS and the world of work (Appendix I) and the accompanying HIV/AIDS and its impact Education and Training Manual contain basic facts about the epidemic and its implications, conditions that contribute to inf HIV and AIDS – the facts vulnerability, and the gender dimension.
    [Show full text]
  • Republic of ARMENIA Country Profile
    Anush PERIKHANYAN MPH Yerevan State Medical University Department of Public Health Republic of ARMENIA Country profile http://www.who.int/countries/arm/en/ 1 Armenia - a lower-middle income country 3-5% (officially)prevalence of HCV among the general population (2013). HCV in 3rd highest rate in CIS countries (Georgia 6.7% Armenia/CIS and Uzbekistan 6.5%) Hepatitis C in Armenia- 44% have HCV genotype 1 37% have genotype 3 19% have genotype 2 Maistat L., Golovin S., Deineka O. and T, Khan. Hepatitis C in Eastern Europe and Central Asiа: Civil Society Respone to the Epidemics; 2015. http://www.aidsalliance.org.ua/ru/news/pdf/28.10.2015/EECA%20HCV%20EN.pdf. Accessed November 9, 2015 injecting drug users imprisoned persons patients getting hemodialysis commercial sex workers patients with tuberculosis healthcare workers oncological patients healthy population 70% HCV among 60% different groups is: people who inject drugs; 50% people who use intranasal drugs; recipients of infected blood products or 40% invasive procedures in health-care facilities with inadequate infection control practices ; children born to mothers infected with HCV ; 30% people with sexual partners who are HCV- infected; 20% people with HIV infection; prisoners or previously incarcerated persons; 10% people who have had tattoos or piercings 0% 1 2 In 2015 effective N3691 order-A “Methodological guideline for epidemiological management of viral Management hepatitis B, C”. of Hepatitis C The epidemiological control of viral hepatitis C is done by the National Center for Disease Control of the in Armenia Republic of Armenia (NCDC), which provides methodological management of prevention and regular control activities of HCV.
    [Show full text]
  • Qualitative Study to Explore the Knowledge and Attitude of Pregnant Women Regarding HIV/AIDS Testing in Kotayk Region and in Yerevan, Armenia
    Qualitative study to explore the knowledge and attitude of pregnant women regarding HIV/AIDS testing in Kotayk region and in Yerevan, Armenia Utilizing Professional Publication Framework Henrik Khachatryan, MD, MPH candidate, American University of Armenia Primary Adviser: M. Thompson, MS, DrPH Secondary Adviser: K. White, RN, PhD, CNAA October 2005 Table of Contents INTRODUCTION ...........................................................................................................................................................1 Background Information and Literature review....................................................................................................1 Rationale for the Research and Research Questions.............................................................................................4 METHODS AND MATERIALS........................................................................................................................................5 Study design...........................................................................................................................................................5 Study population ....................................................................................................................................................5 Sampling and Study Setting...................................................................................................................................6 Data collection Instrument.....................................................................................................................................6
    [Show full text]
  • CURRICULUM VITAE Updated on Jan 24, 2020
    T. Davtyan, Armenia CURRICULUM VITAE Updated on Jan 24, 2020 Surname Davtyan First name(s) Tigran Affiliation and official address Rhea Pharmaceutical Armenia LLC Armenia, 0084, Yerevan Gusan Sherami St., 2 Building (Malatia-Sebastia adm. district) Republic of Armenia Tel.: (+374-) 91 400994, 98-55-96-29 E-mail: [email protected] [email protected] Present Positions: Professor, Chief Scientist Rhea Pharmaceutical Armenia LLC Home address: Michurin str. 5, 23, 375041, Yerevan, Republic of Armenia. Tel: +374 10 55-96-29 Date and Place of birth: 1 December, 1966, Yerevan, Armenia Nationality: Armenian Citizenship: Republic of Armenia Passport ARM, AH0248176, 24 OCT 2006, 009 ID № 1112660259 Marital status: Married, has 2 children, 3 grandchild Education (degrees, dates, universities) 2016 Professor. Field: Biology 2003 Doctor of Biological Sciences (ScD). Field: Molecular Biology 1993 Candidate of Biological Sciences (Ph.D); Field :Genetics and Immunology 1989-1992 Ph.D. student, Laboratory of Genetic Mechanisms of Cell Malignization And Differentiation, Institute of Cytology, St. Petersburg, Russia. 1983-1988 Yerevan State Medical University, Faculty of Pharmacy Specialization (specify) Drug Design and quality control, HIV/AIDS and clinical immunology; Viral infections; immunity and stress resistance; Molecular mechanisms and Genetic regulation of innate immune response; Autoinflammation; 1 T. Davtyan, Armenia Career/Employment (employers, positions and dates) 2011- 2019 Director of Analytical Laboratory of Scientific Centre of Drug and Medical Thechnology Experttise JSC 1999 - 2011 Head of HIV-Clinical Trail Laboratory of the ARMENICUM Research Center, Yerevan, Rep. of Armenia. 1998 - 2006 Consultant on Science, Laboratory of Immunology, The Second Clinical Hospital of the Yerevan State Medical University, Rep.
    [Show full text]
  • AMA-MSS Guide to Organizing a World AIDS Day Event
    MSS Guide to Organizing a World AIDS Day Event What’s inside? Instructions for Organizing your Event Pages 2-6 • Objectives • Materials • Event overview - day of the event • Step-by-step instructions and timeline • Funding sources • Follow-up Flier Template to Promote your Event Page 7 HIV/AIDS Movies Page 8 Media Advisory Template Page 9 Media Advisory Example Page 10 Objectives 1. Educate individuals about the impact of HIV and AIDS in the global community as well as your own. 2. Provide exhibits, speakers, movie screenings, demonstrations, and/or screenings focused towards individuals in your community. 3. Organize with different organizations and healthcare providers in the community to generate goodwill 4. Generate positive publicity for those organizations and individuals who are devoting their time for the benefit of World AIDS Day. 5. Empower participants with a better understanding of the many means in which they can help with the global AIDS epidemic. Back to top Materials 1. Laptop Computers for Possible Demonstrations and Mini-Workshops 2. Projectors to Enhance Computer or Personal Presentations 3. Materials for Featured Event – Discussion Forum, Speaker, Movie Screening 4. Fliers 5. Camera 6. Handouts – Relevant Information regarding the global AIDS epidemic Back to top World AIDS Day Forum – Day of the Event (December 1st) 1. Opening Remarks • General introduction, including a moment of thanks, to all of the different organizations for volunteering their time and/or money. • Explain the objective of the event as stated above. • Describe the schedule for the participants. There may be many items or there may be very few but make sure that all participants know what is offered.
    [Show full text]
  • Partners with Mixed HIV Status
    Partners With Mixed HIV Status SERODISCORDANT RELATIONSHIPS Relationships in which one or more people has HIV and one or more people do not have HIV are sometimes called serodiscordant or mixed serostatus. The term serodiscordant is made up of two roots: 1. Sero—meaning blood 2. Discordant—meaning different or non-matching HIV isn’t the first topic that comes up when most people start dating. You may not know the HIV status of your partner(s). You might not even have been tested yourself. It can be very difficult to talk about HIV status. WHAT ARE THE SPECIAL ISSUES FOR SERODISCORDANT RELATIONSHIPS? People in mixed HIV status relationships face all the same things as other people in relationship. But there are some extra issues: The partner(s) with HIV might focus on not infecting their partner(s). The partner(s) who do not have HIV may concentrate on taking care of the person/people with HIV. This can cause a serious lack of balance in the relationship. HIV can cause changes in the body. Antiretroviral medications (ARVs) may have unpleasant side effects. This might give the partner(s) with HIV negative feelings about their body and their health. It may be difficult to feel attractive and have a normal romantic relationship. Fear of transmitting HIV can cause an excess of caution. This might even stop all sexual activity. Review the following fact sheets for more information: Stopping the Spread of HIV Safer Sex Guidelines Condoms Ways HIV is Transmitted Try to have open discussions about your desires, your fears, and your limits.
    [Show full text]
  • HIV/AIDS: China's Titanic Peril
    HIV/AIDS: China's Titanic Peril 2001 Update of the AIDS Situation and Needs Assessment Report by The UN Theme Group on HIV/AIDS in China HIV/AIDS: China's Titanic Peril 2001 Update of the AIDS Situation and Needs Assessment Report This report was prepared by the UN Theme Group on HIV/AIDS in China for the UN Country Team June 2002 2 HIV/AIDS: China’s Titanic Peril Glossary of Abbreviations AIDS Acquired Immune Deficiency Syndrome CBO Community Based Organisation CCA Common Country Assessment CCTV Central Chinese Television CNY Chinese Yuan (December 2001: 1USD = 8.26 Chinese Yuan) DALY Disability Adjusted Life Year GONGO Government-organised NGO GIPA Greater Involvement of People Infected with or Affected by HIV/AIDS HIV Human Immunodeficiency Virus IEC Information Education Communication IDU Injecting Drug User KAP Knowledge Attitude Practice MOH Ministry of Health MSF Médecins Sans Frontières NGO Non-governmental Organisation PAF Programme Acceleration Funds PLWHA People Living with HIV/AIDS RTI Reproductive Tract Infections SFPC The State Family Planning Commission STD Sexually Transmitted Diseases STI Sexually Transmitted Infections TB Tuberculosis UNAIDS Joint United Nations Programme on HIV/AIDS UNDAF United Nations Development Assistance Framework UNDCP United Nations Drug Control Programme UNDP United Nations Development Programme UNFPA United Nations Population Fund UNGASS United Nations General Assembly Special Session on HIV/AIDS UNICEF United Nations Children’s Fund USD United States Dollar UNTG United Nations Theme Group
    [Show full text]
  • CRUCIAL CONVERSATIONS for PEERS: a FRESH APPROACH Page | 1 Acknowledgments
    CRUCIAL CONVERSATIONS FOR PEERS: A FRESH APPROACH Page | 1 ACKNOWLEDGMENTS This manual has been made possible by the efforts and expertise of the following dedicated contributors, key stakeholders, and organisations that are committed to supporting the HEAIDS peer education programme in the higher education sector. • The HEAIDS Project Team: Dr Ramneek Ahluwalia, Ms Brenda White, Ms Managa Pillay and other members of HEAIDS who contributed towards the development of the manual. • Funders: The development of this training manual would not have been possible without the generous support of Department of Higher Education and Training. • Service Provider: The contracted service provider Wildflower Projects who developed Crucial Conversations for Peers: A Fresh Approach. • Partner Organisations: Our appreciation goes to the following organisations for providing training material and content that was used in the development of this manual: • The Centre for Communication Impact and partners - Department of Health, USAID and PEPFAR for their contribution of the Zazi, and Brothers for Life material. • The Desmond Tutu HIV Foundation and partners COC, ICAP and Centres for Disease Control and Prevention through PEPFAR. • All representatives and contributors from the higher education sector. Permission is granted to use the HEAIDS Peer Educational Manual for educational purposes only and not for financial gain. Page | 2 MESSAGE FROM MDUDUZI MANANA, DEPUTY MINISTER OF HIGHER EDUCATION AND TRAINING The Department of Higher Education and Training strives to identify and deploy effective strategies in order to lead national knowledge generation, advance graduate competency and throughput rates and enable healthy confident graduates to enter the workplace. We invest in education and socio-economic development where investments are needed.
    [Show full text]
  • Sexually Transmitted Diseases Treatment Guidelines, 2015
    Morbidity and Mortality Weekly Report Recommendations and Reports / Vol. 64 / No. 3 June 5, 2015 Sexually Transmitted Diseases Treatment Guidelines, 2015 U.S. Department of Health and Human Services Centers for Disease Control and Prevention Recommendations and Reports CONTENTS CONTENTS (Continued) Introduction ............................................................................................................1 Gonococcal Infections ...................................................................................... 60 Methods ....................................................................................................................1 Diseases Characterized by Vaginal Discharge .......................................... 69 Clinical Prevention Guidance ............................................................................2 Bacterial Vaginosis .......................................................................................... 69 Special Populations ..............................................................................................9 Trichomoniasis ................................................................................................. 72 Emerging Issues .................................................................................................. 17 Vulvovaginal Candidiasis ............................................................................. 75 Hepatitis C ......................................................................................................... 17 Pelvic Inflammatory
    [Show full text]
  • World AIDS Day — December 1, 2015 Lower Levels of Antiretroviral Therapy Enrollment Among Men with HIV Compared with Women
    Morbidity and Mortality Weekly Report Weekly / Vol. 64 / No. 46 November 27, 2015 Lower Levels of Antiretroviral World AIDS Day — Therapy Enrollment Among Men December 1, 2015 with HIV Compared with Women — World AIDS Day, observed on December 1, draws atten- 12 Countries, 2002–2013 tion to the current status of the human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) Andrew F. Auld, MBChB1; Ray W. Shiraishi, PhD1; Francisco Mbofana, MD2; Aleny Couto, MD2; Ernest Benny Fetogang, PhD3; Shenaaz epidemic worldwide. This year’s theme is World AIDS El-Halabi, MPH3; Refeletswe Lebelonyane, MD3; Pilatwe Tlhagiso 2015: The Time to Act is Now. Pilatwe, MSc3; Ndapewa Hamunime, MD4; Velephi Okello, MD5; The first cases of AIDS were reported more than 30 years Tsitsi Mutasa-Apollo, MBChB6; Owen Mugurungi, MD6; Joseph 6 6 7 ago, in the June 5, 1981 issue of MMWR. At the end of Murungu, MD ; Janet Dzangare, MSc ; Gideon Kwesigabo, MD ; Fred Wabwire-Mangen, MD8; Modest Mulenga, MD9; Sebastian Hachizovu, 2014, approximately 36.9 million persons worldwide were MBChB9; Virginie Ettiegne-Traore, MD10; Fayama Mohamed, MSAE11; living with HIV infection (1). Although AIDS-related Adebobola Bashorun, MD12; Do Thi Nhan, MD13; Nguyen Huu Hai, deaths have decreased by 42% since 2004, an estimated MD13; Tran Huu Quang, MSc14; Joelle Deas Van Onacker, MD15; Kesner Francois, MD15; Ermane G. Robin, MD15; Gracia Desforges, 1.2 million persons died from AIDS in 2014 (1). MD15; Mansour Farahani, MD16; Harrison Kamiru, DrPH17; Harriet Global efforts, including the U.S. President’s Emergency Nuwagaba-Biribonwoha, MBChB17; Peter Ehrenkranz, MD18; Julie A.
    [Show full text]
  • Leading Aids Groups Turn up the Heat on '08 Presidential
    Press contacts: David Thorpe | Housing Works | 646-210-1805 | [email protected] Noel Alicea | Gay Men’s Health Crisis | 212-367-1216 | [email protected] Johnathon E. Briggs | AIDS Foundation of Chicago | 312-334-0922 | [email protected] LEADING AIDS GROUPS TURN UP THE HEAT ON ’08 PRESIDENTIAL CANDIDATES Website and new report unearth surprising responses on hot-button HIV/AIDS issues Clinton, Edwards, Obama and Kucinich support ending ban on federal funds for needle exchange New York City, Nov. 28, 2007—Housing Works, Gay Men’s Health Crisis (GMHC), and the AIDS Foundation of Chicago—three of the nation’s leading AIDS organizations—polled 16 presidential hopefuls on pressing AIDS-related issues as part of an ongoing HIV/AIDS candidate and voter education campaign. Now the results are available on AIDSVote.org. “World AIDS Day is this Saturday, but you could also say that World AIDS Day is Election Day 2008. That’s because our next President will have the opportunity and the responsibility to end AIDS,” said Charles King, President and CEO of Housing Works. “She or he will have the tools to treat 33 million people living with HIV—including over a million American s—around the planet, as well as the tools to stop the spread of the virus. We’re here to build the political will to make that happen.” “More than ever, the American public is calling for meaningful health care reform which includes bold leadership in the area of AIDS,” said GMHC Chief Operating Officer Robert Bank. “Voters need to know what the candidates will do to fight AIDS when determining their readiness to be President.” The launch of AIDSVote.org, timed to coincide with World AIDS Day on December 1, features the results of the AIDSVote.org candidate questionnaire and Where Do They Stand? The Gay Men’s Health Crisis Report on the 2008 Presidential Candidates and HIV/AIDS Issues , a detailed portrait of every candidate’s history in public life on HIV/AIDS issues.
    [Show full text]
  • LIST of REGISTRED DRUGS in ARMENIA (Up to 31.12.2017)
    LIST OF REGISTRED DRUGS IN ARMENIA (Up to 31.12.2017) International nonproprietary Registration Term of Legal status for N Trade name name (generic) or Drug form Dose and packaging Manufacturer Country ATC1 code License holder number registration supply active ingredients name Lek Pharmaceuticals pefloxacin Lek Pharmaceuticals 400mg, 10.03.2015 d.d., Verovskova Str. 1 Abaktal (pefloxacin tablets film-coated d.d., Verovskova Str. Slovenia J01MA03 14308 PoM2 in blister (10/1x10/) 10.03.2020 57, 1526 Ljubljana, mesylate dihydrate) 57, 1526 Ljubljana Slovenia Lilly France S.A.S., Eli Lilly Regional 100IU/ml, Zone Industrielle, 2 17.03.2017 Operations GmbH., 2 Abasaglar insulin glargine solution for injection France A10AE04 16535 PoM 3ml cartridges (5) rue du Colonel Lilly, 17.03.2022 Koelblgasse 8-10, 67640 Fegersheim 1030, Vienna, Austria Help S.A ,10 ambroxol Help S.A. Pedini, Valaoritou str., GR 6mg/ml, 09.03.2016 3 Abrobion (ambroxol syrup Ioanninon, Ioannina, Greece R05CB06 15404 OTC3 144 52, 125ml glass bottle 09.03.2021 hydrochloride) 45500 Metamorphosis, Attika, Greece Salutas Pharma GmbH, Otto-von- Guericke-Alle-1, 100mg/5ml, 39179 Barleben-batch Sandoz 30g powder in 75ml glass powder for oral releaser, Allphamed Pharmaceuticals d.d., bottle and measuring 20.10.2015 4 ACC acetylcysteine solution with orange Pharbil Arzneimittel Germany R05CB01 14947 OTC Verovskova Str. 57, spoon 5ml, 60g powder in 20.10.2020 flavour GmbH Hildebrandstr. 1000 Ljubljana, 150ml glass bottle and 12, 37081 Gottingen, Slovenia measuring spoon 5ml Germany-bulk manufacturer, packager 1 Salutas Pharma GmbH, Otto-von- Guericke-Alle-1, 39179 Barleben - Sandoz batch releaser Pharmaceuticals d.d., 100mg, 21.11.2014 5 ACC 100 acetylcysteine tablets effervescent (Hermes Pharma Germany R05CB01 13967 OTC Verovskova Str.
    [Show full text]